- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Emcure Pharmaceuticals reduced Poviztra® (semaglutide injection) prices by 55% for the starting dose, averaging 47% across all doses. This strategic move expands patient access to the weight management drug, now available from Rs. 3,999 monthly, aiming to address India's growing obesity challenge.